Navigation Links
Intermittent Catheter Market to Surpass 40% CAGR Between 2008 and 2012
Date:2/19/2009

New Medicare Reimbursement will have Significant Impact on the Intermittent Catheter Market, according to Millennium Research Group

WALTHAM, Mass., Feb. 19 /PRNewswire/ -- Millennium Research Group (MRG) has updated its US Markets for Urological Devices 2008 report to reflect momentous shifts in the US intermittent catheter market. Due mainly to a favorable upgrade in Medicare reimbursement, the US intermittent catheter market, comprising reusable straight strips, disposable gel-coated strips and trays, and disposable hydrophilic strips, will achieve a compound annual growth rate (CAGR) above 40% between 2008 and 2012.

Effective April 1, 2008, the number of intermittent catheters covered by Medicare increased from four per month to a maximum of 200 catheters per month, promoting single-use catheterization. One of the largest influences driving this change was the November 2007 recommendation from the Department of Veterans Affairs (VA) that its clinicians follow all manufacturer instructions for catheter use, ensuring that catheters classified as single use by manufacturers and the FDA are not reused. In order to provide consistency among government organizations, Medicare reimbursement was changed shortly following recommendations from the Department of VA.

"Also important was that on October 1, 2008, Medicare withdrew reimbursement to hospitals for treating certain conditions that were not present on admission, including catheter-associated urinary tract infections," says Lexie Code, Manager of the Endoscopy division at MRG. "Because intermittent strips are inserted only when the need to drain urine arises and therefore result in fewer infections, hospitals have an additional incentive to adopt these products, further driving market expansion."

MRG's US Markets for Urological Devices 2009 report provides a detailed qualitative and quantitative analysis of the new reimbursement, as well as numerous other urological device markets in the areas of incontinence, prostate cancer, stone management, benign prostatic hyperplasia (BPH), and erectile dysfunction (ED). Coverage of key industry competitors includes American Medical Systems, C.R. Bard, Caldera Medical, Cook Urological, Coloplast, Lumenis, Olympus, Richard Wolf, and many more.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
2. St. Mary Medical Center Opens New Cardiovascular Catheterization Labs Reaffirming Role as a Regional Leader in Cardiovascular Medicine
3. Insightra Medical, Inc. Gains FDA clearance for the Most Complete Range of 7Fr Intra Aortic Balloon (IAB) Catheters
4. Avalon Laboratories receives FDA and European clearances to market 3 catheter devices
5. Avalon Laboratories receives FDA and European clearances to market three catheter devices
6. Innovative Atrial Fibrillation (AF) Catheter Ablation System From Ablation Frontiers is Subject of Two Abstracts at Heart Rhythm Congress UK
7. Concentric Medical Launches Distal Access Catheter
8. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
9. OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
10. Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit
11. Dialysis Catheter Placement Makes Little Difference in Infection Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: